Details

Autor(en) / Beteiligte

• Che, H
• Etcheto, A
• Dernis, E
• Nataf, H
• Boumier, P
• Breuillard, P
• Durandin-Truffinet, M
• Fechtenbaum, J
• Gaud-Listrat, V
• Giraud, B
• Hudry, C
• Labatide-Alanore, S
• Le Devic, P
• Le Goux, P
• Lebrun, A
• Maheu, E
• Moura, B
• Nguyen, M
• Sacchi, A
• Ayral, X
• Blanchais, A
• Neveu, S
• Dougados, M
• Moltó, A

Titel

Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network

Ist Teil von

• Clinical and experimental rheumatology, 2015-11, Vol.33 (6), p.851

Ort / Verlag

Italy

Erscheinungsjahr

2015

Quelle

MEDLINE

Beschreibungen/Notizen

• Nowadays, the recommended measures for optimal monitoring of axial Spondyloarthritis (ax-SpA) disease activity are either BASDAI and CRP, or ASDAS-CRP. However, there could be a gap between recommendations and daily practice. We aimed to determine the measures collected by rheumatologists in an ax-SpA follow-up visit, and to determine the impact of a meeting (where rheumatologists reached a consensus on the measures to be collected) on the collection of such measures. A consensual meeting of a local network of 32 rheumatologists proposed, four months later, to report at least the BASDAI score in the medical file of every ax-SpA patient at every follow-up visit. An independent investigator reviewed the medical files of 10 consecutive patients per rheumatologist, seen twice during the year (e.g. before and after the meeting). The most frequently collected measures were assessed, and then, the frequency of collection before and after the meeting was compared. A total of 456 medical files from 228 patients were reviewed. Treatment (>60%), CRP (51.3%) and total BASDAI (28.5%) were the most reported measures in medical files. Before/After the meeting, the frequencies of collected measures in medical files were 28.5%/51.7%, 51.3%/52.2%, 16.7%/31.6% and 0.9%/6.1% for BASDAI, CRP, BASDAI + CRP and ASDAS, respectively reaching a statistically significance for BASDAI, ASDAS and BASDAI+CRP (p<0.05). This study revealed a low rate of systematic report of the recommended outcome measures in ax-SpA. However, it suggests that a consensual meeting involving practicing rheumatologists might be relevant to improve the implementation of such recommendations.